Scott Motejunas
About Scott Motejunas
Scott Motejunas is a Manager of Product Innovation at Surescripts, where he has worked since 2018, focusing on enhancing provider user experience and driving revenue growth in the healthcare sector. He has a diverse background in corporate strategy, private equity, and consulting, with previous roles at Humana, PowerPlan, Inc., Camden Partners, and Cambridge Associates.
Current Role at Surescripts
Scott Motejunas serves as the Manager of Product Innovation at Surescripts, a position he has held since 2018. In this role, he guides agile teams through the development process, focusing on optimizing the provider user experience and prioritizing future functionality. His responsibilities include identifying strategic partnerships to accelerate growth in the healthcare sector and managing the Benefit Optimization and Insights lines of business. He emphasizes driving revenue growth and optimizing sales enablement.
Previous Experience in Healthcare Strategy
Before joining Surescripts, Scott Motejunas worked at Humana as part of the Corporate Strategy team from 2014 to 2015. His role involved strategic planning and analysis within the healthcare sector. He also served as a Principal Business Advisor at Surescripts from 2015 to 2018, where he contributed to business strategy and product development.
Educational Background
Scott Motejunas holds a Bachelor of Arts in Economics from The Johns Hopkins University. He also studied abroad at the University of Cambridge, focusing on Economics. He furthered his education by obtaining a Master of Business Administration (MBA) from the University of Virginia Darden School of Business. Additionally, he graduated with a diploma from Milton Academy.
Professional Contributions and Presentations
Scott Motejunas has actively contributed to discussions on healthcare technology and patient safety. He presented at the Pharmacy Benefit Management Institute in 2018, focusing on the use of technology and actionable patient intelligence to improve patient care while reducing costs. He also participated as a speaker at the FDA Advisory Committee for Medication Adherence in 2018 and co-presented at the Surescripts Customer Forum and the Medical Group Management Association in 2016.
Early Career Experience
Scott Motejunas began his career as a Consulting Associate at Cambridge Associates from 2008 to 2010, where he provided analytical support for investment strategies. He then worked as a Private Equity Investment Analyst at Camden Partners from 2010 to 2012, focusing on investment analysis and strategy. In 2013, he served as an MBA Strategy Intern at PowerPlan, Inc. for three months, gaining experience in corporate strategy.